Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000806592-22-000009
Filing Date
2022-04-22
Accepted
2022-04-22 08:43:58
Documents
94
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 SUNWIN STEVIA INTERNATIONAL, INC. - FORM 10-Q suwn-20220131.htm   iXBRL 10-Q 606208
2 SECTION 302 CERTIFICATE OF THE CHIEF EXECUTIVE OFFICER sunw_ex31z1.htm EX-31.1 7535
3 SECTION 302 CERTIFICATE OF CHIEF FINANCIAL OFFICER sunw_ex31z2.htm EX-31.2 7509
4 SECTION 906 CERTIFICATE OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER sunw_ex32z1.htm EX-32.1 5086
  Complete submission text file 0000806592-22-000009.txt   3613290

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT suwn-20220131_cal.xml EX-101.CAL 28649
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT suwn-20220131_def.xml EX-101.DEF 36860
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT suwn-20220131_lab.xml EX-101.LAB 216660
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT suwn-20220131_pre.xml EX-101.PRE 179328
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT suwn-20220131.xsd EX-101.SCH 65566
88 EXTRACTED XBRL INSTANCE DOCUMENT suwn-20220131_htm.xml XML 455634
Mailing Address 6 SHENGWANG AVENUE, QUFU, SHANDONG F4 273100
Business Address 6 SHENGWANG AVENUE, QUFU, SHANDONG F4 273100 (86) 537-4424999
SUNWIN STEVIA INTERNATIONAL, INC. (Filer) CIK: 0000806592 (see all company filings)

EIN.: 562416925 | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-53595 | Film No.: 22843540
SIC: 2834 Pharmaceutical Preparations